While some authors found that the decline of GH and/or IGF-1 concentration predicted tumour shrinkage in therapy naive patients, other could not demonstrate a correlation between biochemical efficacy and tumour shrinkage [117]. This evidence concerns the gene GH1 and neoplasm.